Beyfortus
-
AstraZeneca says it will prioritize U.S. market for RSV drugAstraZeneca AZN.L on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus.HealthNov 10, 2023
-
‘It’s a game-changer’: New drug to protect babies from RSV approvedHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.CanadaApr 22, 2023
